Ledger Run 获得Asentia,用于加强服务和ClinRun平台整合。 Ledger Run acquires Assentia for enhanced services and ClinRun platform integration.

Ledger Run公司已经收购了Asentia公司,该公司是一家以其全球临床试验合同谈判专门知识而闻名的制药服务供应商。 Ledger Run has acquired Assentia, a pharmaceutical services provider known for its global clinical trial contract negotiation expertise. 购置的目的是加强Ledger Run的服务,补充其ClinRun平台,促进赞助者、网站和CRO更好地参与。 This acquisition aims to enhance Ledger Run's services and complement its ClinRun platform, facilitating better engagement among sponsors, sites, and CROs. 合并将扩大供应,加快向病人提供创新疗法和装置,使制药和生物技术部门受益。 The merger will expand offerings and accelerate the delivery of innovative therapies and devices to patients, benefiting the pharmaceutical and biotech sectors.